Hold Parameters on Likely Cardiovascular Depressant Medications
This pilot study is being pursued to observe whether certain medications are given to patients within a timeframe where their being given could play a part in a critical event in the management of the patient.
There are general rules about when it would be appropriate for these types of medications not to be given. However, it is not current standard practice for the criteria to be put in place without the expressed wishes of the ordering physician or their agent.
Can the administration of cardio-depressant medications be documented as a significant risk factor for hypotensive or bradycardic events?
|Study Design:||Time Perspective: Retrospective|
|Official Title:||Hold Parameters on Likely Cardiovascular Depressant Medications (HOLD)|
Please refer to this study by its ClinicalTrials.gov identifier: NCT00527709
|United States, New Jersey|
|Hackensack University Medical Center|
|Hackensack, New Jersey, United States, 07601|
|Principal Investigator:||Amit Tailor, MD, MBA||Hackensack University Medical Center|